Exclusive special offer and discount title banner vector image

GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Global Multiplex Assay Market by Product and Service (Reagents and Consumables, Instruments and Accessories, Software and Services) Market by Type (Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Types) Market by Application (Research and Development, Clinical Diagnostics, Companion Diagnostics) Market by Technology (Multiplex Protein Microarray, Multiplex Pcr, Other Technologies) Market by End-user (Pharmaceutical & Biotechnology Companies, Research Institutes, Clinical Laboratories, Hospitals) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The global multiplex assay market size was $3833.21 million in 2023 and is expected to reach $7793.26 million by 2032, growing at a CAGR of 8.12% during the forecast period, 2024-2032. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032.

Multiplex assays allow for the simultaneous detection and quantification of multiple analytes, such as proteins, nucleic acids, or metabolites, within a single sample. Unlike traditional singleplex assays, which focus on one target at a time, multiplex assays enable researchers to study several molecules concurrently. Different types of multiplex assays, such as ELISA multiplex assays and Luminex multiplex assays, allow for the detection of various proteins, cytokines, and biomarkers in biological samples.

The adoption of multiplex assays has surged due to their efficiency, cost-effectiveness, and ability to generate comprehensive datasets. One of the primary advantages of multiplex assays is their capability to analyze multiple targets concurrently, conserving time and resources while maximizing sample utilization. The demand for multiplex assays continues to grow across diverse fields, including pharmaceuticals, clinical diagnostics, and academic research.

Furthermore, multiplex assays offer a streamlined approach to studying complex biological systems, enabling researchers to gain deeper insights into disease mechanisms and drug responses. Specific applications include multiplex protein assays for studying protein interactions, Luminex multiplex assays for measuring multiple cytokines (signaling molecules), and multiplex cytokine assays for monitoring immune responses.

Moreover, ongoing multiplex assay development aims to expand capabilities and applications, resulting in diverse multiplex assay kits targeting specific needs. For instance, Multiplex MSD (Meso Scale Discovery) is another technology platform gaining traction

Multiplex Assay Market

Read our latest blog on the Multiplex Assay Market

GROWTH ENABLERS

Key growth enablers of the global multiplex assay market are: 

  • Escalating incidence of chronic diseases
    • The World Health Organization (WHO) states that approximately 70% of global deaths are attributed to chronic diseases, such as noncommunicable diseases (NCDs), totaling 41 million deaths each year. Major NCDs, including cardiovascular diseases, cancers, diabetes, and chronic lung diseases, significantly contribute to this mortality.
    • The increasing incidence of these chronic conditions is driving the growth of the multiplex assay market. These assays represent sophisticated diagnostic techniques capable of analyzing multiple analytes simultaneously in a single assay cycle, providing a comprehensive disease profile for patients.
  • Growing preference for multiplex assays over conventional approaches
  • Increasing acceptance of personalized medicine

GROWTH RESTRAINTS

Key growth restraining factors of the global multiplex assay market are:

  • Overcoming the difficulty of establishing sufficient assay ranges
  • Challenges associated with cross-reactivity and assay interference
    • Cross-reactivity and assay interference present significant challenges in the field of multiplex assays. These issues can restrict the assay’s performance, hinder the scalability of multiplexing, and potentially yield inaccurate or false results.
    • Cross-reactivity (CR) occurs when an antibody mistakenly interacts with an unintended antigen, leading to false-positive outcomes. This problem is particularly concerning in multiplex assays, where multiple analytes are assessed simultaneously. The complex composition of biological matrices exacerbates cross-reactivity, as they often contain interconnected proteins, isoforms, and precursors that can disrupt the assay process.
  • Shortage of skilled professionals

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Multiplex Assay Market | Top Trends

  • Multiplex assays are increasingly used in the drug discovery process. Cell-based assays are becoming more popular because they are more accurate and cost-effective than traditional drug testing methods like animal testing. These tests use cells to see how effective a drug is, how safe it is, and how toxic it might be. This further makes drug discovery faster and less expensive.
  • Precision medicine is a way of treating patients, considering their individual differences. This approach is increasing the use of companion diagnostics, which are tests that help doctors decide the best treatment for a patient. These tests often need to look at many different things at once, which is where multiplex assays come in. As more people use precision medicine and companion diagnostics, the demand for multiplex assays will also increase.

MARKET SEGMENTATION

Market Segmentation – Product and Service, Type, Technology, Application, and End-User –Market by Product and Service:
  • Reagents and Consumables
  • Instruments and Accessories
  • Software and Services
Market by Type:
  • Protein-Based Multiplex Assay
    • Protein-based multiplex assays are utilized to identify and quantify proteins, extensively employed for diagnosing and detecting various diseases, including cancer, infectious diseases, and others.
    • Moreover, protein-based multiplex assays facilitate the easy study of functional analysis of proteins and protein-protein interaction.
  • Nucleic Acid-Based Multiplex Assay
  • Other Multiplex Assays
Market by Technology:
  • Multiplex Protein Microarray
  • Multiplex PCR
  • Other Technologies
Market by Application:
  • Research and Development
  • Clinical Diagnostics
    • Clinical laboratories utilize multiplex assays to test and diagnose various diseases such as cancer, HIV, and more.
    • The adoption of multiplex assays is on the rise in these laboratories as they streamline the workload of lab technicians by enabling the simultaneous analysis of multiple analytes, thereby saving time and effort.
  • Companion Diagnostics
Market by End-User:
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Clinical Laboratories
  • Hospitals

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions: 

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Australia & New Zealand, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific 
    • The Asia-Pacific multiplex assay market growth is supplemented by the increasing demand for healthcare infrastructure, the rising number of hospitals in emerging countries, and the developing R&D sector. Additionally, the increasing healthcare reforms and technological advancements in healthcare boost market growth.
    • China is the dominating country in Asia-Pacific in the life science research space. It also boasts a thriving discovery industry. Moreover, due to advancements in genomics, combinatorial chemistry, and HTS, China has emerged as a major location to which drug discovery is being outsourced, thereby propelling the requirement of multiplex assays.
  • Rest of World: Latin America, and Middle East & Africa

MAJOR PLAYERS

The major players in the global multiplex assay market are:

  • Agilent Technologies Inc
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Merck Millipore
  • Qiagen NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc

Key strategies adopted by some of these companies:

  • In August 2023, Qiagen announced the expansion of its Digital PCR technology for the development of cell and gene therapies.
  • In March 2023, Illumina introduced Illumina Complete Long Read Prep, Human, which is compatible with the Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. Illumina Complete Long Reads streamlines the workflow and significantly reduces DNA input requirements compared to other long-read options.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast Units

Revenue ($ Million)

Segments AnalyzedProduct and Service, Type, Technology, Application, and End-User
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedAbcam, Agilent Technologies Inc, Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc, Bio-Techne Corporation, Cellcarta, F. Hoffmann-La Roche Ltd, Illumina Inc, Merck Millipore, Olink Proteomics AB, Qiagen NV, Randox Laboratories Ltd, Seegene Inc, Siemens Healthineers AG, Thermo Fisher Scientific Inc
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
    5. MAJOR MARKET FINDINGS
      1. SOFTWARE AND SERVICES SECTOR EMERGES AS THE RAPIDLY EXPANDING PRODUCT & SERVICE SEGMENT
      2. PROTEIN-BASED MULTIPLEX ASSAY IS THE HIGHEST REVENUE-GENERATING TYPE
      3. RESEARCH & DEVELOPMENT APPLICATIONS DOMINATE MARKET SHARE
      4. MULTIPLEX PCR TECHNOLOGY DEMONSTRATES FASTER GROWTH
      5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE MAJOR USERS OF MULTIPLEX ASSAYS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. ESCALATING INCIDENCE OF CHRONIC DISEASES
      2. GROWING PREFERENCE FOR MULTIPLEX ASSAYS OVER CONVENTIONAL APPROACHES
      3. INCREASING ACCEPTANCE OF PERSONALIZED MEDICINE
    2. KEY RESTRAINTS
      1. OVERCOMING THE DIFFICULTY OF ESTABLISHING A SUFFICIENT ASSAY RANGE
      2. CHALLENGES ASSOCIATED WITH CROSS-REACTIVITY AND ASSAY INTERFERENCE
      3. SHORTAGE OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. RISING DRUG DISCOVERY ENDEAVORS
      2. PROGRESS IN ASSAY PLATFORM TECHNOLOGY
      3. RAPID EXPANSION OF COMPANION DIAGNOSTICS
    2. PORTER’S FIVE FORCES MODEL
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
      2. GROWTH PROSPECT MAPPING FOR GERMANY
      3. GROWTH PROSPECT MAPPING FOR INDIA
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
    6. KEY BUYING CRITERIA
      1. COVERAGE OF ANALYTES
      2. RAPIDITY
      3. ABILITY TO MULTIPLEX
      4. USER-FRIENDLINESS
      5. AUTOMATION POTENTIAL
    7. VALUE CHAIN ANALYSIS
      1. RESEARCH AND DEVELOPMENT (R&D)
      2. MANUFACTURING AND PRODUCTION
      3. DISTRIBUTION AND SUPPLY CHAIN
      4. CLINICAL APPLICATION AND DATA ANALYSIS
      5. MARKET RESEARCH AND COMMERCIALIZATION
  5. MARKET BY PRODUCT AND SERVICE
    1. REAGENTS AND CONSUMABLES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. INSTRUMENTS AND ACCESSORIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. SOFTWARE AND SERVICES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY TYPE
    1. PROTEIN-BASED MULTIPLEX ASSAY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTHER TYPES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY APPLICATION
    1. RESEARCH AND DEVELOPMENT
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. CLINICAL DIAGNOSTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. COMPANION DIAGNOSTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. MARKET BY TECHNOLOGY
    1. MULTIPLEX PROTEIN MICROARRAY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. MULTIPLEX PCR
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTHER TECHNOLOGIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  9. MARKET BY END-USER
    1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. RESEARCH INSTITUTES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. CLINICAL LABORATORIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    4. HOSPITALS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  10. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA MULTIPLEX ASSAY MARKET DRIVERS
      3. NORTH AMERICA MULTIPLEX ASSAY MARKET CHALLENGES
      4. KEY PLAYERS IN NORTH AMERICA MULTIPLEX ASSAY MARKET
      5. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE MULTIPLEX ASSAY MARKET DRIVERS
      3. EUROPE MULTIPLEX ASSAY MARKET CHALLENGES
      4. KEY PLAYERS IN EUROPE MULTIPLEX ASSAY MARKET
      5. COUNTRY ANALYSIS
        1. GERMANY
          1. GERMANY MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        2. UNITED KINGDOM
          1. UNITED KINGDOM MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        6. BELGIUM
          1. BELGIUM MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC MULTIPLEX ASSAY MARKET DRIVERS
      3. ASIA-PACIFIC MULTIPLEX ASSAY MARKET CHALLENGES
      4. KEY PLAYERS IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET
      5. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        4. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        5. SOUTH KOREA
          1. SOUTH KOREA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        7. INDONESIA
          1. INDONESIA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        8. VIETNAM
          1. VIETNAM MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD MULTIPLEX ASSAY MARKET DRIVERS
      3. REST OF WORLD MULTIPLEX ASSAY MARKET CHALLENGES
      4. KEY PLAYERS IN REST OF WORLD MULTIPLEX ASSAY MARKET
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. ABCAM
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      2. AGILENT TECHNOLOGIES INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      3. BECTON, DICKINSON AND COMPANY (BD)
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      4. BIO-RAD LABORATORIES INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      5. BIO-TECHNE CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      6. CELLCARTA
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      7. F. HOFFMANN-LA ROCHE LTD
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      8. ILLUMINA INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      9. MERCK MILLIPORE
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      10. OLINK PROTEOMICS AB
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      11. QIAGEN NV
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      12. RANDOX LABORATORIES LTD
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      13. SEEGENE INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
      14. SIEMENS HEALTHINEERS AG
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      15. THERMO FISHER SCIENTIFIC INC
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY

TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 20: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 22: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 24: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 28: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 30: GLOBAL MULTIPLEX PCR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL MULTIPLEX PCR MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 32: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 34: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 36: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 38: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 39: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 40: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 42: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 43: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 44: GLOBAL MULTIPLEX ASSAY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: GLOBAL MULTIPLEX ASSAY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 46: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 47: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 48: KEY PLAYERS OPERATING IN NORTH AMERICA MULTIPLEX ASSAY MARKET

TABLE 49: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 50: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 51: KEY PLAYERS OPERATING IN EUROPE MULTIPLEX ASSAY MARKET

TABLE 52: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 53: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 54: KEY PLAYERS OPERATING IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET

TABLE 55: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 56: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 57: KEY PLAYERS OPERATING IN REST OF WORLD MULTIPLEX ASSAY MARKET

TABLE 58: LIST OF MERGERS & ACQUISITIONS

TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 61: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY

FIGURE 5: GROWTH PROSPECT MAPPING FOR INDIA

FIGURE 6: MARKET MATURITY ANALYSIS

FIGURE 7: MARKET CONCENTRATION ANALYSIS

FIGURE 8: KEY BUYING CRITERIA

FIGURE 9: VALUE CHAIN ANALYSIS

FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY PRODUCT AND SERVICE, IN 2023

FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $ MILLION)

FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN $ MILLION)

FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $ MILLION)

FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023

FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)

FIGURE 16: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)

FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)

FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $ MILLION)

FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $ MILLION)

FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $ MILLION)

FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2023

FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032 (IN $ MILLION)

FIGURE 24: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)

FIGURE 25: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $ MILLION)

FIGURE 26: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023

FIGURE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)

FIGURE 28: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)

FIGURE 29: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $ MILLION)

FIGURE 30: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 31: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 32: UNITED STATES MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 33: CANADA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 34: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 35: GERMANY MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 36: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 37: FRANCE MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 38: ITALY MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 39: SPAIN MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 40: BELGIUM MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 41: POLAND MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 42: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 43: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 44: CHINA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 45: JAPAN MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 46: INDIA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 47: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 48: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 49: THAILAND MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 50: INDONESIA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 51: VIETNAM MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 52: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 53: REST OF WORLD MULTIPLEX ASSAY MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 54: LATIN AMERICA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 55: MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FAQ’s

FAQs

The multiplex assay market is anticipated to generate a revenue of $7793.26 million in 2032.

Asia-Pacific is projected to witness significant growth in the global multiplex assay market.

As of 2023, North America holds the largest share of the global multiplex assay market.

Request Customization
Request Customization
Request Customization